Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
2,27 USD | +1,34 % | -10,63 % | -22,53 % |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 34 | 01/01/16 | |
Steven Kelly
CEO | Chief Executive Officer | 59 | 01/02/18 |
Richard Morris
DFI | Director of Finance/CFO | 51 | 01/06/21 |
Daniel Cushing
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/17 |
Tom Wilton
PRN | Corporate Officer/Principal | - | 01/09/19 |
Terry Shields
HRO | Human Resources Officer | - | 14/06/23 |
Eric Siegel
LAW | General Counsel | 60 | 14/06/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Steven Kelly
CEO | Chief Executive Officer | 59 | 01/02/18 |
Sanford Zweifach
CHM | Chairman | 68 | 01/11/21 |
Director/Board Member | 66 | 01/02/22 | |
Regina Hodits
BRD | Director/Board Member | 54 | 01/06/18 |
Briggs Morrison
BRD | Director/Board Member | 65 | 01/07/20 |
Chidozie Ugwumba
BRD | Director/Board Member | 41 | 01/12/20 |
Michael Torok
BRD | Director/Board Member | 45 | 07/03/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 40 356 806 | 26 759 751 ( 66,31 %) | 0 | 66,31 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-22,53 % | 90,4 M | |
+2,73 % | 108 mil M | |
+9,59 % | 104 mil M | |
+6,58 % | 23,66 mil M | |
-12,59 % | 22,1 mil M | |
-3,29 % | 19,71 mil M | |
-35,36 % | 18,2 mil M | |
-13,29 % | 16,19 mil M | |
+4,68 % | 13,72 mil M | |
+34,25 % | 12,22 mil M |
- Bolsa
- Acciones
- Acción Carisma Therapeutics, Inc. - Nasdaq
- Empresa Carisma Therapeutics, Inc.